A total of 116 patients were randomized to receive bevacizumab 3 mg/ kg every 2 weeks (n=39), 10 mg/ kg every 2 weeks; (n=37), or placebo (n=40).
Se aleatorizaron un total de 116 pacientes para recibir bevacizumab 3 mg/ kg cada 2 semanas (n = 39), 10 mg/ kg cada 2 semanas; (n = 37), o placebo (n = 40).